284 related articles for article (PubMed ID: 10662779)
21. Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration.
Sun J; Marx SO; Chen HJ; Poon M; Marks AR; Rabbani LE
Circulation; 2001 Jun; 103(24):2967-72. PubMed ID: 11413088
[TBL] [Abstract][Full Text] [Related]
22. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.
Rivard N; Boucher MJ; Asselin C; L'Allemain G
Am J Physiol; 1999 Oct; 277(4):C652-64. PubMed ID: 10516095
[TBL] [Abstract][Full Text] [Related]
23. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).
Laufs U; Marra D; Node K; Liao JK
J Biol Chem; 1999 Jul; 274(31):21926-31. PubMed ID: 10419514
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
25. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE
Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805
[TBL] [Abstract][Full Text] [Related]
26. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
27. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Hupfeld CJ; Weiss RH
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
29. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
30. Lovastatin inhibits mesangial cell proliferation via p27Kip1.
Terada Y; Inoshita S; Nakashima O; Yamada T; Kuwahara M; Sasaki S; Marumo F
J Am Soc Nephrol; 1998 Dec; 9(12):2235-43. PubMed ID: 9848777
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
32. Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced vascular smooth muscle cells proliferation and upregulates the expressions of p27Kip1 and p2lCip1.
Yu HZ; Xie LD; Zhu PL; Xu CS; Wang HJ
Mol Cell Biochem; 2012 Jan; 360(1-2):363-71. PubMed ID: 21959973
[TBL] [Abstract][Full Text] [Related]
33. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
[TBL] [Abstract][Full Text] [Related]
34. Effects of dominant-negative c-Jun on platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
Zhan Y; Kim S; Yasumoto H; Namba M; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):82-8. PubMed ID: 11788465
[TBL] [Abstract][Full Text] [Related]
35. [Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell].
Yuan Y; Xu DL; Liu YL; Jia MY
Sheng Li Xue Bao; 1999 Jun; 51(3):285-90. PubMed ID: 11498990
[TBL] [Abstract][Full Text] [Related]
36. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1.
Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L
J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727
[TBL] [Abstract][Full Text] [Related]
37. Involvement of p27(kip1) in ceramide-mediated apoptosis in HL-60 cells.
Kim WH; Ghil KC; Lee JH; Yeo SH; Chun YJ; Choi KH; Kim DK; Kim MY
Cancer Lett; 2000 Apr; 151(1):39-48. PubMed ID: 10766421
[TBL] [Abstract][Full Text] [Related]
38. PDGF-BB-mediated activation of CREB in vascular smooth muscle cells alters cell cycling via Rb, FoxO1 and p27
Perrault R; Molnar P; Poole J; Zahradka P
Exp Cell Res; 2021 Jul; 404(1):112612. PubMed ID: 33895117
[TBL] [Abstract][Full Text] [Related]
39. Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis.
Inui H; Kitami Y; Tani M; Kondo T; Inagami T
J Biol Chem; 1994 Dec; 269(48):30546-52. PubMed ID: 7982973
[TBL] [Abstract][Full Text] [Related]
40. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM
J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
